Korean Circ J.  2018 Jan;48(1):80-81. 10.4070/kcj.2017.0356.

J-curve Phenomenon Might Be Inherent: How to Know If It Is Treatment Induced?

• Shin J

• KMID: 2405048
• DOI: http://doi.org/10.4070/kcj.2017.0356

Abstract

No abstract available.

MeSH Terms

Antihypertensive Agents
Hypertension
Blood Pressure
Myocardial Ischemia
telmisartan
Ramipril
Risk Factors
Antihypertensive Agents
Ramipril

Reference

1. Kimm H, Mok Y, Lee SJ, Lee S, Back JH, Jee SH. The J-curve between diastolic blood pressure and risk of all-cause and cardiovascular death. Korean Circ J. 2018; 48:36–47.

2. McEvoy JW, Chen Y, Rawlings A, et al. Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control. J Am Coll Cardiol. 2016; 68:1713–1722.

3. Bellamy RF. Diastolic coronary artery pressure-flow relations in the dog. Circ Res. 1978; 43:92–101.

4. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP. INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med. 2002; 136:438–448.

5. Kalkman DN, Brouwer TF, Vehmeijer JT, et al. J curve in patients randomly assigned to different systolic blood pressure targets: an experimental approach to an observational paradigm. Circulation. 2017; 136:2220–2229.

6. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension. 2005; 45:907–913.